Northern epilepsy, a new member of the NCL family

Citation
S. Ranta et Ae. Lehesjoki, Northern epilepsy, a new member of the NCL family, NEUROL SCI, 21(3), 2000, pp. S43-S47
Citations number
20
Categorie Soggetti
Neurology
Journal title
NEUROLOGICAL SCIENCES
ISSN journal
15901874 → ACNP
Volume
21
Issue
3
Year of publication
2000
Supplement
S
Pages
S43 - S47
Database
ISI
SICI code
1590-1874(2000)21:3<S43:NEANMO>2.0.ZU;2-7
Abstract
Northern epilepsy, or progressive epilepsy with mental retardation (EPMR), is an autosomal recessive disorder characterized by normal early developmen t, onset of generalized tonic-clonic seizures between the ages of 5 and 10 years, and subsequent progressive mental retardation. The seizures increase in frequency until puberty after which the epileptic activity starts to de cline. Mental retardation begins 2-5 years after the onset of seizures and continues through adulthood. Neuropathological findings have shown that EPM R is a new member (CLN8) of the neuronal ceroid lipofuscinosis (NCL) group of neurodegenerative disorders. The CLN8 gene was identified recently. It e ncodes a 286 amino acid putative transmembrane protein with no homology to previously known proteins. Subsequently, the homologous mouse gene (Cln8) w as sequenced and localized to the region of the mouse genome linked to moto r neuron degeneration, mouse mnd. Mnd is a naturally occurring mouse mutant with intracellular autofluorescent inclusions similar to those seen in hum an CLN8. A mutation in mnd mouse DNA was identified, indicating that mnd is a murine model for CLN8.